CLIC2

CLIC2 is a monomeric member of the GST structural family that functions principally as a regulator of intracellular Ca2+ release by binding and modulating ryanodine receptor channels (PMID:15147738, PMID:17945253, PMID:19356589). In its water-soluble form CLIC2 adopts a GST fold, and unlike CLIC1 it forms an intramolecular disulfide and remains monomeric across redox conditions; it forms pH-dependent chloride channels in vitro that are more active at low pH and subject to redox regulation (PMID:17945253). CLIC2 binds directly to the clamp-shaped region of RyR1 (between domains 5 and 6), inducing a conformational change, increasing ryanodine binding affinity, decreasing channel open probability by prolonging mean closed time, and reducing Ca2+ efflux from sarcoplasmic reticulum vesicles (PMID:19356589); it acts comparably on cardiac RyR2 (PMID:15147738). This modulation is redox-dependent, with CLIC2 inhibiting RyR2 under oxidizing conditions and activating it under reducing conditions, dependent on GSH:GSSG buffer on both luminal and cytoplasmic channel faces (PMID:18522493). CLIC2 also promotes sub-conductance RyR openings and reduces FKBP association with RyRs (PMID:28851804). The X-linked H101Q mutation converts CLIC2 from an RyR inhibitor into a gain-of-function activator that prolongs channel opening and amplifies Ca2+ signals, causing a channelopathy presenting with intellectual disability, atrial fibrillation, cardiomegaly, and seizures in affected males (PMID:22814392). Beyond its RyR role, lower-confidence findings place CLIC2 in extracellular MMP14/MMP2 inhibition (PMID:36230813) and in macrophage differentiation via Shp1/Stat3 (PMID:40696397).

1. 1997 Medium

   Established the existence and genomic identity of CLIC2 as a candidate chloride channel gene, defining the molecular entity before any function was known.

   Evidence cDNA cloning, sequence alignment, and genomic structure determination mapping the gene to Xq28

   PMID:9339381

   Open questions at the time

   • No functional or biochemical characterization of the protein
   • Homology-based annotation only; channel activity unproven
2. 2004 High

   Answered what CLIC2 actually does by demonstrating it is an inhibitor of cardiac RyR2 Ca2+ release channels, shifting the protein from a presumed chloride channel to an RyR regulator.

   Evidence Lipid bilayer single-channel recording, SR vesicle Ca2+ efflux assay, and antibody reversal; enzyme activity assays showing low glutathione peroxidase but no thiol transferase activity

   PMID:15147738

   Open questions at the time

   • RyR binding site not localized
   • Redox dependence of the interaction not yet defined
3. 2007 High

   Resolved the structural basis of CLIC2, placing it in the GST structural family and explaining why it remains monomeric, while defining a candidate protein-recognition interface.

   Evidence 1.8-Å X-ray crystallography in two crystal forms, site-directed mutagenesis, and in vitro channel recording

   PMID:17945253

   Open questions at the time

   • The 'foot-in-mouth' interface as the RyR-binding site was inferred, not demonstrated
   • Soluble-to-membrane transition mechanism unresolved
4. 2008 Medium

   Showed that CLIC2's effect on RyR is not fixed but redox-switched, establishing CLIC2 as a redox-sensitive bidirectional modulator.

   Evidence Lipid bilayer single-channel recording with controlled GSH:GSSG redox buffer on both channel faces

   PMID:18522493

   Open questions at the time

   • Single lab, single method
   • Molecular identity of the redox sensor residues not mapped
5. 2009 High

   Pinpointed where and how CLIC2 binds RyR1, converting a functional inhibition into a structurally defined interaction with a measured conformational consequence.

   Evidence [3H]ryanodine binding, Ca2+ efflux assay, lipid bilayer single-channel recording, and cryo-EM localization to the clamp region between domains 5 and 6

   PMID:19356589

   Open questions at the time

   • Atomic-resolution contacts at the interface not resolved
   • Whether the same site mediates RyR2 binding not directly tested
6. 2011 Low

   Proposed a structural rationale for how the disease mutation H101Q alters CLIC2, framing it as a defect in conformational flexibility and membrane association.

   Evidence In silico molecular dynamics simulation and electrostatics calculations

   PMID:21630357

   Open questions at the time

   • Computational prediction only, no experimental validation of the predicted structural effects
   • Link to functional channel behavior not established at this stage
7. 2012 High

   Connected CLIC2 to human disease and established the mutation mechanism: H101Q is a gain-of-function variant that activates rather than inhibits RyR, causing an X-linked channelopathy.

   Evidence Exome sequencing for gene identification plus functional lipid bilayer electrophysiology of RyR channels with H101Q mutant protein

   PMID:22814392

   Open questions at the time

   • How loss of H101 produces activation rather than simple loss of inhibition not fully mechanistically resolved
   • Tissue-specific contributions to the multisystem phenotype unclear
8. 2017 Medium

   Refined the mechanism by showing both WT and mutant CLIC2 promote sub-conductance RyR openings and displace FKBP, distinguishing how the same biophysical change yields opposite physiological outcomes.

   Evidence Lipid bilayer single-channel recording, FKBP-RyR binding assays, and pharmacological manipulation with rapamycin and FK506

   PMID:28851804

   Open questions at the time

   • Single lab
   • Physiological relevance of FKBP displacement in vivo not established
9. 2022 Low

   Extended CLIC2 beyond intracellular Ca2+ signaling by reporting a secreted, extracellular role inhibiting MMP14 and downstream MMP2 activation.

   Evidence Secretory-granule localization, CLIC2–MMP14 binding assay, and MMP activity assay, as described in a review citing primary data

   PMID:36230813

   Open questions at the time

   • Mechanistic claims drawn from a review citing primary data, not independently replicated here
   • Secretion mechanism and physiological context underdefined
10. 2025 Medium

    Identified an intracellular signaling role in immune-cell differentiation, linking CLIC2 to Shp1/Stat3 control of monocyte-to-macrophage transition.

    Evidence CRISPR knock-out in THP-1 cells with flow cytometry, cytokine profiling, phosphorylation westerns, and CLIC2 interaction assays with Shp1 and Stat3

    PMID:40696397

    Open questions at the time

    • Single study, no independent replication
    • Direct vs. indirect nature of Shp1/Stat3 interactions not resolved
    • Relationship to the RyR/Ca2+ role unknown

• How CLIC2 transitions between its soluble GST-fold form, its membrane-inserted chloride-channel form, its RyR-bound regulatory form, and its secreted MMP-inhibitory form within a single cellular context remains unresolved.
• No unifying model linking the channel, RyR-modulator, secreted, and signaling roles
• Atomic structure of any CLIC2–partner complex unresolved
• Endogenous redox conditions governing inhibition vs. activation in vivo not defined